替米沙坦晨服对比晚服对高血压患者诊疗有效性综合评价.docVIP

替米沙坦晨服对比晚服对高血压患者诊疗有效性综合评价.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
替米沙坦晨服对比晚服对高血压患者诊疗有效性综合评价

精品论文 参考文献 替米沙坦晨服对比晚服对高血压患者诊疗有效性综合评价 葛晓平   (浙江省天台县白鹤中心卫生院 浙江天台 317201)   【摘要】目的 探讨晨服和晚服替米沙坦对高血压患者诊疗的临床效果。方法 将我院2010年1月至2013年1月期间收治的共168例高血压患者分成晨服和夜服组,各为79例患者,治疗后观察SBP/DBP、dSBP/DBP和nSBP/DBP等指标,并进行对比分析。结果 两组患者经过治疗后,部分患者由非杓型高血压改变为杓型高血压。而晨服组为19例,占24.1%;夜服组为51例,占64.6%,两组治疗后,检验结果具有显著差异(Plt;0.01)。同时两组患者在SBP和DBP上进行对比分析,并无显著差异(Pgt;0.05),而在治疗前后两组患者具有显著差异(Plt;0.01)。结论 替米沙坦药物能够帮助患者显著降低高血压,达到保护人体器官等方面的作用,可帮助患者改善夜晚血压起伏,减少非杓型血压患者的例数,值得大力推广。   【关键词】替米沙坦 晨服 晚服 高血压   【中图分类号】R453 【文献标识码】A 【文章编号】2095-1752(2014)06-0217-02      The comprehensive evaluation of treatment in patients with hypertension by taking telmisartan with late service compared with morning service   【Abstract】Objective: To investigate the comprehensive evaluation of treatment in patients with hypertension by taking telmisartan with late service compared with morning service. Methods: 168 patients were lived in our hospital to receive treatment between January 2010 and January 2013. All patients were divided into two groups with 79 patients respectively. After treatment, the SBP/DBP、dSBP/DBP and nSBP/DBP of morning and evening group were comparatively analyzed. Results: After treatment, some patients from non-dipper hypertensive had turned into the dipper hypertension. The morning service group was 19 cases, accounting for 24.1%; night service group was 51 cases, accounting for 64.6%. The two groups were tested with significant difference (Plt;0.01). Meanwhile, two groups of patients in SBP and DBP were analyzed with no significant difference (Pgt;0.05) while the two groups of patients before and after treatment was tested with a significant difference (Plt;0.01).Conclusion: Telmisartan drugs can help patients significantly reduce high blood pressure and protect human organs. It also can help patients improve blood pressure fluctuations at night so that reduce the number of cases of non-dipper hypertensive patients, so it is worth promoting.   【Keywords】

文档评论(0)

sheppha + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5134022301000003

1亿VIP精品文档

相关文档